Related references
Note: Only part of the references are listed.Gastrointestinal bleeding and the risk of colorectal cancer in anticoagulated patients with atrial fibrillation
Peter Vibe Rasmussen et al.
EUROPEAN HEART JOURNAL (2022)
Twice- or Once-Daily Dosing of Direct Oral Anticoagulants, a systematic review and meta-analysis
S. Mainbourg et al.
THROMBOSIS RESEARCH (2021)
Update on Guidelines for the Management of Cancer-Associated Thrombosis
Michael B. Streiff et al.
ONCOLOGIST (2021)
Risk of Major Gastrointestinal Bleeding With New vs Conventional Oral Anticoagulants: A Systematic Review and Meta-analysis
Zhi-Chun Gu et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2020)
Reduced dose of rivaroxaban and dabigatran vs. vitamin K antagonists in very elderly patients with atrial fibrillation in a nationwide cohort study
Laurent Fauchier et al.
EUROPACE (2020)
Apixaban and dalteparin in active malignancy-associated venous thromboembolism: The ADAM VTE trial
Robert D. McBane et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)
Oral Anticoagulant Prescription Trends, Profile Use, and Determinants of Adherence in Patients with Atrial Fibrillation
Sylvie Perreault et al.
PHARMACOTHERAPY (2020)
Direct oral anticoagulants for cancer-associated venous thromboembolism: a systematic review and meta-analysis
Frits Mulder et al.
BLOOD (2020)
Trends in anticoagulant prescribing: a review of local policies in English primary care
Katherine H. Ho et al.
BMC HEALTH SERVICES RESEARCH (2020)
Drug-Drug Interactions with Direct Oral Anticoagulants
Kathrin I. Foerster et al.
CLINICAL PHARMACOKINETICS (2020)
Impact of Modifiable Bleeding Risk Factors on Major Bleeding in Patients With Atrial Fibrillation Anticoagulated With Rivaroxaban
Paulus Kirchhof et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2020)
Apixaban for the Treatment of Venous Thromboembolism Associated with Cancer
Giancarlo Agnelli et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Direct Oral Anticoagulant Use: A Practical Guide to Common Clinical Challenges
Ashley Chen et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2020)
2020 ACC Expert Consensus Decision Pathway on Management of Bleeding in Patients on Oral Anticoagulants A Report of the American College of Cardiology Solution Set Oversight Committee
Gordon F. Tomaselli et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)
Drug-drug interactions with direct oral anticoagulants associated with adverse events in the real world: A systematic review
Allen Li et al.
THROMBOSIS RESEARCH (2020)
Stroke and Bleeding Risk Assessments in Patients With Atrial Fibrillation: Concepts and Controversies
Wern Yew Ding et al.
FRONTIERS IN MEDICINE (2020)
Clinical Pharmacokinetics and Pharmacodynamics of Direct Oral Anticoagulants in Patients with Renal Failure
Roberto Padrini
EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS (2019)
Ischemic stroke risk estimation in patients without oral anticoagulation: an observational cohort study based on secondary data from Germany
Felix S. Wicke et al.
BMC CARDIOVASCULAR DISORDERS (2019)
Effectiveness and Safety of Four Direct Oral Anticoagulants in Asian Patients With Nonvalvular Atrial Fibrillation
Yi-Hsin Chan et al.
CHEST (2019)
Comparison of Hemospray® and Endoclot™ for the treatment of gastrointestinal bleeding
Francesco Vitali et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2019)
Oral anticoagulation therapy use in patients with atrial fibrillation after the introduction of non-vitamin K antagonist oral anticoagulants: findings from the French healthcare databases, 2011-2016
Geric Maura et al.
BMJ OPEN (2019)
Effectiveness and Safety of Direct Oral Anticoagulants versus Vitamin K Antagonists for People Aged 75 Years and over with Atrial Fibrillation: A Systematic Review and Meta-Analyses of Observational Studies
Anneka Mitchell et al.
JOURNAL OF CLINICAL MEDICINE (2019)
Use of direct oral anticoagulant in atrial fibrillation with gastrointestinal bleeding: Balancing gastrointestinal safety and cardiovascular risks
Joseph J. Y. Sung et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2019)
Comparison of Once-Daily Administration of Edoxaban and Rivaroxaban in Asian Patients with Atrial Fibrillation
So-Ryoung Lee et al.
SCIENTIFIC REPORTS (2019)
Clinical Management of Pharmacokinetic Drug Interactions with Direct Oral Anticoagulants (DOACs)
Megan C. Herink et al.
DRUGS (2019)
It's time for head-to-head trials with direct oral anticoagulants
Tobias Tritschler et al.
THROMBOSIS RESEARCH (2019)
Perioperative Management of Patients With Atrial Fibrillation Receiving a Direct Oral Anticoagulant
James D. Douketis et al.
JAMA INTERNAL MEDICINE (2019)
Sensitivity and specificity of an algorithm based on medico-administrative data to identify hospitalized patients with major bleeding presenting to an emergency department
Emmanuel Oger et al.
BMC MEDICAL RESEARCH METHODOLOGY (2019)
2019 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer
Dominique Farge et al.
LANCET ONCOLOGY (2019)
Direct oral anticoagulants in gastrointestinal malignancies: is the convenience worth the risk?
Namisha Thapa et al.
JOURNAL OF GASTROINTESTINAL ONCOLOGY (2019)
Clinical and endoscopic features of severe acute gastrointestinal bleeding in elderly patients treated with direct oral anticoagulants: a multicentre study
David Deutsch et al.
THERAPEUTIC ADVANCES IN GASTROENTEROLOGY (2019)
Two-year follow-up of patients treated with dabigatran for stroke prevention in atrial fibrillation: Global Registry on Long-Term Antithrombotic Treatment in Patients with Atrial Fibrillation (GLORIA-AF) registry
Menno V. Huisman et al.
AMERICAN HEART JOURNAL (2018)
Severity of Gastrointestinal Bleeding in Patients Treated with Direct-Acting Oral Anticoagulants
Mark M. Brodie et al.
AMERICAN JOURNAL OF MEDICINE (2018)
Emergency care of patients receiving non-vitamin K antagonist oral anticoagulants
J. W. Eikelboom et al.
BRITISH JOURNAL OF ANAESTHESIA (2018)
Gastrointestinal Bleeding With Edoxaban Versus Warfarin: Results From the ENGAGE AF-TIMI 48 Trial (Effective Anticoagulation With Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis In Myocardial Infarction)
James Aisenberg et al.
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES (2018)
Rebleeding vs Thromboembolism After Hospitalization for Gastrointestinal Bleeding in Patients on Direct Oral Anticoagulants
Neil Sengupta et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2018)
Locations and Mucosal Lesions Responsible for Major Gastrointestinal Bleeding in Patients on Warfarin or Dabigatran
Jennifer M. Kolb et al.
DIGESTIVE DISEASES AND SCIENCES (2018)
The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation
Jan Steffel et al.
EUROPEAN HEART JOURNAL (2018)
Management of patients on antithrombotic agents undergoing emergency and elective endoscopy: joint Asian Pacific Association of Gastroenterology (APAGE) and Asian Pacific Society for Digestive Endoscopy (APSDE) practice guidelines
Francis K. L. Chan et al.
GUT (2018)
Comparison of an Oral Factor Xa Inhibitor With Low Molecular Weight Heparin in Patients With Cancer With Venous Thromboembolism: Results of a Randomized Trial (SELECT-D)
Annie M. Young et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Role of direct oral anticoagulants in the treatment of cancer-associated venous thromboembolism: guidance from the SSC of the ISTH
A. A. Khorana et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2018)
Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism
Gary E. Raskob et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Adherence to rivaroxaban versus apixaban among patients with non-valvular atrial fibrillation: Analysis of overall population and subgroups of prior oral anticoagulant users
Colleen A. McHorney et al.
PLOS ONE (2018)
Efficacy and safety of direct oral anticoagulants approved for cardiovascular indications: Systematic review and metaanalysis
Raghavendra Charan P. Makam et al.
PLOS ONE (2018)
Gastrointestinal Bleeding With Edoxaban Versus Warfarin: Results From the ENGAGE AF-TIMI 48 Trial (Effective Anticoagulation With Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis In Myocardial Infarction)
James Aisenberg et al.
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES (2018)
Risks and benefits of direct oral anticoagulants versus warfarin in a real world setting: cohort study in primary care
Yana Vinogradova et al.
BMJ-BRITISH MEDICAL JOURNAL (2018)
Difference between the Upper and the Lower Gastrointestinal Bleeding in Patients Taking Nonvitamin K Oral Anticoagulants
Kyohei Maruyama et al.
BIOMED RESEARCH INTERNATIONAL (2018)
Risks and benefits of direct oral anticoagulants versus warfarin in a real world setting: cohort study in primary care
Yana Vinogradova et al.
BMJ-BRITISH MEDICAL JOURNAL (2018)
The use of direct oral anticoagulants in chronic kidney disease
Kathrine Parker et al.
BRITISH JOURNAL OF HAEMATOLOGY (2018)
Long-term outcome in patients with non-valvular atrial fibrillation on dabigatran: a prospective cohort study
Paolo Verdecchia et al.
EXPERT OPINION ON DRUG SAFETY (2018)
Association of Oral Anticoagulants and Proton Pump Inhibitor Cotherapy With Hospitalization for Upper Gastrointestinal Tract Bleeding
Wayne A. Ray et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2018)
Predictors of pre-procedural concentrations of direct oral anticoagulants: a prospective multicentre study
Anne Godier et al.
EUROPEAN HEART JOURNAL (2017)
Gastrointestinal Safety of Direct Oral Anticoagulants: A Large Population-Based Study
Neena S. Abraham et al.
GASTROENTEROLOGY (2017)
Non-Vitamin K Antagonist Oral Anticoagulant Dosing in Patients With Atrial Fibrillation and Renal Dysfunction
Xiaoxi Yao et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)
Dissociation between the pharmacokinetics and pharmacodynamics of once-daily rivaroxaban and twice-daily apixaban: a randomized crossover study
R. Kreutz et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2017)
Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease
J. W. Eikelboom et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Rivaroxaban or Aspirin for Extended Treatment of Venous Thromboembolism
J. I. Weitz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Gastrointestinal bleeding in patients on novel oral anticoagulants: Risk, prevention and management
Ka-Shing Cheung et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2017)
Sex-Specific Comparative Effectiveness of Oral Anticoagulants in Elderly Patients With Newly Diagnosed Atrial Fibrillation
Ghanshyam Palamaner Subash Shantha et al.
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES (2017)
Risk of Gastrointestinal Bleeding in Patients Taking Non-Vitamin K Antagonist Oral Anticoagulants: A Systematic Review and Meta-analysis
Corey S. Miller et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2017)
Trends in the prescription of novel oral anticoagulants in UK primary care
Simone Y. Loo et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2017)
Major Gastrointestinal Bleeding Often Is Caused by Occult Malignancy in Patients Receiving Warfarin or Dabigatran to Prevent Stroke and Systemic Embolism From Atrial Fibrillation
Kathryn F. Flack et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2017)
Direct Oral Anticoagulants: A Quick Guide
Julia Sikorska et al.
EUROPEAN CARDIOLOGY REVIEW (2017)
Direct oral anticoagulants and digestive bleeding: therapeutic management and preventive measures
David Deutsch et al.
THERAPEUTIC ADVANCES IN GASTROENTEROLOGY (2017)
Risk of gastrointestinal bleeding with direct oral anticoagulants: a systematic review and network meta-analysis
Nick Burr et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2017)
How to choose appropriate direct oral anticoagulant for patient with nonvalvular atrial fibrillation
Jordan K. Schaefer et al.
ANNALS OF HEMATOLOGY (2016)
XANTUS: a real-world, prospective, observational study of patients treated with rivaroxaban for stroke prevention in atrial fibrillation
A. John Camm et al.
EUROPEAN HEART JOURNAL (2016)
Antithrombotic Therapy for VTE Disease CHEST Guideline and Expert Panel Report
Clive Kearon et al.
CHEST (2016)
Evidence-Based Development and Rationale for Once-Daily Rivaroxaban Dosing Regimens Across Multiple Indications
Dagmar Kubitza et al.
CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS (2016)
Endoscopy in patients on antiplatelet or anticoagulant therapy, including direct oral anticoagulants: British Society of Gastroenterology (BSG) and European Society of Gastrointestinal Endoscopy (ESGE) guidelines
Andrew M. Veitch et al.
ENDOSCOPY (2016)
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
Paulus Kirchhof et al.
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY (2016)
Point-of-Care Warfarin Monitoring in the ROCKET AF Trial
J. Robert Powell
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Edoxaban: A Comprehensive Review of the Pharmacology and Clinical Data for the Management of Atrial Fibrillation and Venous Thromboembolism
Zachary A. Stacy et al.
CARDIOLOGY AND THERAPY (2016)
Adherence to non-vitamin-K-antagonist oral anticoagulant medications based on the Pharmacy Quality Alliance measure
Colleen A. McHorney et al.
CURRENT MEDICAL RESEARCH AND OPINION (2015)
Diagnosis and management of nonvariceal upper gastrointestinal hemorrhage: European Society of Gastrointestinal Endoscopy (ESGE) Guideline
Ian M. Gralnek et al.
ENDOSCOPY (2015)
Why do we need observational studies of everyday patients in the real-life setting?
Alexander T. Cohen et al.
EUROPEAN HEART JOURNAL SUPPLEMENTS (2015)
Expanding consensus in portal hypertension Report of the Baveno VI Consensus Workshop: Stratifying risk and individualizing care for portal hypertension
Roberto de Franchis
JOURNAL OF HEPATOLOGY (2015)
Gastrointestinal Bleeding in Patients With Atrial Fibrillation Treated With Rivaroxaban or Warfarin ROCKET AF Trial
Matthew W. Sherwood et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2015)
Gastrointestinal bleeding in patients receiving oral anticoagulation: Current treatment and pharmacological perspectives
Alessandro Di Minno et al.
THROMBOSIS RESEARCH (2015)
The role of factor Xa inhibitors in venous thromboembolism treatment
Katherine P. Cabral et al.
VASCULAR HEALTH AND RISK MANAGEMENT (2015)
Treatment of Acute Venous Thromboembolism With Dabigatran or Warfarin and Pooled Analysis
Sam Schulman et al.
CIRCULATION (2014)
Major Bleeding in Patients With Atrial Fibrillation Receiving Apixaban or Warfarin
Elaine M. Hylek et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials
Christian T. Ruff et al.
LANCET (2014)
Observational study of the effects of dabigatran on gastrointestinal symptoms in patients with non-valvular atrial fibrillation
Takeshi Yamashita et al.
JOURNAL OF ARRHYTHMIA (2014)
Guideline on the management of bleeding in patients on antithrombotic agents
Mike Makris et al.
BRITISH JOURNAL OF HAEMATOLOGY (2013)
Genetic Determinants of Dabigatran Plasma Levels and Their Relation to Bleeding
Guillaume Pare et al.
CIRCULATION (2013)
Projections on the number of individuals with atrial fibrillation in the European Union, from 2000 to 2060
Bouwe P. Krijthe et al.
EUROPEAN HEART JOURNAL (2013)
Edoxaban versus Warfarin in Patients with Atrial Fibrillation
Robert P. Giugliano et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Oral Apixaban for the Treatment of Acute Venous Thromboembolism
Giancarlo Agnelli et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Gastrointestinal bleeding with the new oral anticoagulants - defining the issues and the management strategies
Jay Desai et al.
THROMBOSIS AND HAEMOSTASIS (2013)
Rivaroxaban and other novel oral anticoagulants: pharmacokinetics in healthy subjects, specific patient populations and relevance of coagulation monitoring
Wolfgang Mueck et al.
THROMBOSIS JOURNAL (2013)
Oral Direct Factor Xa Inhibitors Versus Low-Molecular-Weight Heparin to Prevent Venous Thromboembolism in Patients Undergoing Total Hip or Knee Replacement A Systematic Review and Meta-analysis
Ignacio Neumann et al.
ANNALS OF INTERNAL MEDICINE (2012)
Rivaroxaban vs. Warfarin in Japanese Patients With Atrial Fibrillation - The J-ROCKET AF Study
Masatsugu Hori et al.
CIRCULATION JOURNAL (2012)
Bleeding Risk with Dabigatran in the Frail Elderly
Paul Harper et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Bleeding During Treatment With Aspirin Versus Apixaban in Patients With Atrial Fibrillation Unsuitable for Warfarin The Apixaban Versus Acetylsalicylic Acid to Prevent Stroke in Atrial Fibrillation Patients Who Have Failed or Are Unsuitable for Vitamin k Antagonist Treatment (AVERROES) Trial
Greg C. Flaker et al.
STROKE (2012)
Modelling and simulation of edoxaban exposure and response relationships in patients with atrial fibrillation
Daniel E. Salazar et al.
THROMBOSIS AND HAEMOSTASIS (2012)
Risk of Bleeding With 2 Doses of Dabigatran Compared With Warfarin in Older and Younger Patients With Atrial Fibrillation An Analysis of the Randomized Evaluation of Long-Term Anticoagulant Therapy (RE-LY) Trial
John W. Eikelboom et al.
CIRCULATION (2011)
Apixaban in Patients with Atrial Fibrillation
Stuart J. Connolly et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Apixaban versus Warfarin in Patients with Atrial Fibrillation
Christopher B. Granger et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
Manesh R. Patel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Oral Rivaroxaban for Symptomatic Venous Thromboembolism.
Rupert Bauersachs et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Randomised, parallel-group, multicentre, multinational phase 2 study comparing edoxaban, an oral factor Xa inhibitor, with warfarin for stroke prevention in patients with atrial fibrillation
Jeffrey I. Weitz et al.
THROMBOSIS AND HAEMOSTASIS (2010)
Proton pump inhibitor treatment initiated prior to endoscopic diagnosis in upper gastrointestinal bleeding
Aravamuthan Sreedharan et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2010)
Dabigatran versus Warfarin in Patients with Atrial Fibrillation.
Stuart J. Connolly et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Dabigatran versus Warfarin in the Treatment of Acute Venous Thromboembolism.
Sam Schulman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
The metabolism and disposition of the oral direct thrombin inhibitor, dabigatran, in humans
Stefan Blech et al.
DRUG METABOLISM AND DISPOSITION (2008)
Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence
Yoko Miyasaka et al.
CIRCULATION (2006)
Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients
S Schulman et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2005)
Sex differences and the effects of sex hormones on hemostasis and vascular reactivity
DW Schwertz et al.
HEART & LUNG (2001)
Share Paper
